2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Leukemia, Prolymphocytic, B-Cell
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Myeloid, Acute
2
Study of Risk Factors for IPMNs Degeneration at the Nancy CHRU
1
Stomach Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Extranodal NK-T-Cell
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Myeloid
1
Leukemia, Large Granular Lymphocytic
1
Immunoblastic Lymphadenopathy
1
Enteropathy-Associated T-Cell Lymphoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Sensitivity and Specificity
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Study of Risk Factors for IPMNs Degeneration at the Nancy CHRU
×
Sensitivity and Specificity
×
Clear all
NCT04901364
2021-05-25
IPMN
Central Hospital, Nancy, France
Unknown
57 enrolled